Department of Pharmacology, University of Oxford, Oxford, UK.
School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK.
Eur J Neurosci. 2022 Mar;55(6):1409-1423. doi: 10.1111/ejn.15623. Epub 2022 Mar 3.
The antidepressant vortioxetine has high affinity for the ionotropic 5-HT receptor (5-HT R) as well as other targets including the 5-HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhibits cortical 5-HT R-expressing interneurons (5-HT R-INs) to disinhibit excitatory pyramidal neurons. The current study determined for the first time the effect of vortioxetine on the in vivo firing of putative 5-HT R-INs whilst simultaneously recording pyramidal neuron activity using cortical slow-wave oscillations as a readout. Extracellular single unit and local field potential recordings were made in superficial layers of the prefrontal cortex of urethane-anaesthetised rats. 5-HT R-INs were identified by a short-latency excitation evoked by electrical stimulation of the dorsal raphe nucleus (DRN). Juxtacellular-labelling found such neurons had the morphological and immunohistochemical properties of 5-HT R-INs: basket cell or bipolar cell morphology, expression of 5-HT R-IN markers and parvalbumin-immunonegative. Vortioxetine inhibited the short-latency DRN-evoked excitation of 5-HT R-INs and simultaneously decreased cortical slow wave oscillations, indicative of pyramidal neuron activation. Likewise, the 5-HT R antagonist ondansetron inhibited the short-latency DRN-evoked excitation of 5-HT R-INs. However unlike vortioxetine, ondansetron did not decrease cortical slow-wave oscillations, suggesting a dissociation between this effect and inhibition of 5-HT R-INs. The 5-HT reuptake inhibitor escitalopram had no consistent effect on any electrophysiological parameter measured. Overall, the current findings suggest that vortioxetine simultaneously inhibits (DRN-evoked) 5-HT R-INs and excites pyramidal neurons, thereby changing the excitatory:inhibitory balance in cortex. However, under the current experimental conditions, these two effects were dissociable with only the former likely involving a 5-HT R-mediated mechanism.
抗抑郁药文拉法辛对离子型 5-羟色胺受体(5-HT R)具有高亲和力,同时还对其他靶点具有亲和力,包括 5-羟色胺转运体。文拉法辛的认知促进作用与皮层中兴奋性抑制平衡的改变有关。因此,文拉法辛据称通过抑制皮层 5-HT R 表达中间神经元(5-HT R-IN)来抑制兴奋性锥体神经元。目前的研究首次确定了文拉法辛对活体中假定的 5-HT R-IN 放电的影响,同时使用皮质慢波振荡作为读出记录锥体神经元的活动。在麻醉的大鼠前额叶皮层的浅层进行了细胞外单单元和局部场电位记录。通过电刺激背侧中缝核(DRN)诱发的短潜伏期兴奋来鉴定 5-HT R-IN。细胞内标记发现这些神经元具有 5-HT R-IN 的形态和免疫组织化学特性:篮状细胞或双极细胞形态、5-HT R-IN 标志物和 parvalbumin-免疫阴性表达。文拉法辛抑制了 5-HT R-IN 的短潜伏期 DRN 诱发兴奋,同时降低了皮质慢波振荡,表明锥体神经元被激活。同样,5-HT R 拮抗剂昂丹司琼也抑制了 5-HT R-IN 的短潜伏期 DRN 诱发兴奋。然而,与文拉法辛不同的是,昂丹司琼不会降低皮质慢波振荡,表明这种作用与抑制 5-HT R-IN 之间存在分离。5-HT 再摄取抑制剂艾司西酞普兰对测量的任何电生理参数均无一致影响。总的来说,目前的研究结果表明,文拉法辛同时抑制(DRN 诱发)5-HT R-IN 和兴奋锥体神经元,从而改变皮层中的兴奋性抑制平衡。但是,在当前的实验条件下,这两种作用是可分离的,只有前者可能涉及 5-HT R 介导的机制。